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To further define the role offibrin(ogen) and fibronectin in Staphylococcus aureusadherence to
central venous catheters, the amount, chemical integrity, and biologic activity of these proteins
adsorbed on lines inserted in hospitalized patients were prospectively studied. Polyurethane
cannulas promoted a significantly lower adherence of S. aureusthan polyvinyl chloride (P < .01)
or Hickman (P < .001) cannulas and contained the lowest amount of immunologically assayed
fibronectin but not offibrin(ogen). Fibrinogen showed an extensive loss of adherence-promoting
activity on inserted cannulas, which was related to its proteolytic breakdown, as detected by
SDS-PAGE and immunoblots with antifibrinogen antibodies and confirmed by in vitro studies
with purified protein fragments. In contrast, either intact or fragmented fibronectin, although
present in much lower amounts than fibrin(ogen), could actively promote S. aureusadherence
onto intravenous catheters.
Microbial colonization of intravascular devices is an im-
portant source of nosocomial infection and sepsis [1, 2].
Such device-related infections are frequently due to staphylo-
cocci and represent a major risk to the patients receiving
intravenous (iv) therapy [I, 2]. Several factors may explain
the frequent colonization of iv devices by Staphylococcus
aureus, Staphylococcus epidermidis, or other species ofcoagu-
lase-negative staphylococci: First, the presence ofa transcuta-
neous cannula wound allowing skin microorganisms to mi-
grate across the skin barrier [1, 2]; second, the microbial
production of mucoid exopolymeric substances enhancing
the stickiness of colonizing organisms [3-6]; and third, the
presence of plasma proteins adsorbed on iv devices, which
might selectively promote staphylococcal attachment to
their surfaces [7-10].
We have reported that plasma proteins deposited on
various categories of iv catheters removed from patients
played a significant role in staphylococcal adherence [11].
Clinical isolates of S. aureus were more strongly promoted
for adherence by cannula-adsorbed plasma proteins than
clinical isolates of S. epidermidis [11]. This observation was
explained in part by the more frequent occurrence ofclinical
[8, 12, 13] and laboratory [14-23] isolates ofS. aureus than
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of S. epidermidis on surface determinants recognizing some
major plasma or matrix proteins, such as fibronectin [8, 10-
12, 14-18], fibrinogen [9, 16, 19-21], collagen [13, 17], lam-
inin [8, 17, 22], or vitronectin [23]. Each of these individual
proteins is known to promote staphylococcal adherence
when adsorbed in vitro on polymeric surfaces [8-10]. In our
in vivo study, we also found that on cannulas inserted in
patients, most of the adherence-promoting activity was me-
diated via surface-bound fibronectin and fibrinogen or fibrin
[11]. However, the respective roles of each of these protein
components in staphylococcal adherence could not be pre-
cisely evaluated [11].
The objectives ofthis study were to quantify the respective
content of surface-bound fibronectin versus fibrinogen/
fibrin on inserted catheters and to define the role played by
each of these proteins in the bacterial attachment process in
vivo.
Materials and Methods
Collection ofcatheters. iv catheters from adult inpatients at-
tending the Clinique Medicale Therapeutique at Geneva Univer-
sity Hospital were consecutively removed for a 3-month period
by a team of 2 trained nurses. We followed a previously de-
scribed [11] protocol to collect clinical and laboratory data from
each patient, except that only central and peripherally inserted
central venous catheters were evaluated. A total of 65 central
catheters inserted for an average of 9-11 days was collected.
Inserted cannulas were 14 polyvinyl chloride (PVC) long lines
(14-gauge Drum-Cartridge [Abbott, Sligo, Ireland] and 16-
gauge Intracath [Deseret, Sandy, UT]) and 51 16-gaugepolyure-
thane (PUR) catheters of three different types. Twenty cannulas
were Vialon (PUR-V; Deseret), 18 were Cavafix (PUR-C,
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Seldiflex (PUR-S; Plastimed, Saint-Leu, France). In addition,
IS previously inserted Hickman 9.6-French single lumen can-
nulas (Evermed, Cranston, RI) were collected from outpatients
of the Oncology Unit of our hospital. There was no significant
difference between PVC and PUR cannulas in the average dura-
tion of insertion. Similar proportions of iv catheters have been
used for administering antimicrobial therapy, blood products,
anticoagulants, or total parenteral nutrition in PVC and PUR
cannula groups. The major reason for catheter removal was the
end of iv therapy. When catheter-associated infection was sus-
pected, semiquantitative cultures were done as described by
Maki [2]; only one ofthese catheters showed significant tip colo-
nization (> IS cfu), and no patient in this series had device-re-
lated bacteremia.
To quantify the volume of residual blood still associated with
inserted cannulas after the rinsing procedure, done as previously
described [II], we assayed the activity of endogenous peroxi-
dase as a marker of contaminating red blood cells. Segments (I
em long) of inserted cannulas were incubated for IS min at
37°C with 0.0 I% H20 2 and the chromogen 1,2-phenylenedia-
mine dihydrochloride (OPD; Dakopatts, Glostrup, Denmark)
according to the manufacturer's instructions. The content of
endogenous peroxidase assayed by optical density readings at
492 mm in standard volumes of serially diluted whole blood
incubated in parallel was used to estimate the volume ofresidual
blood still associated with segments of previously inserted can-
nulas. A minimal amount (5 X 10- 6 mL) of whole blood was
detected by the colorimetric assay, which was linear up to 10-4
mL. A cutoff point of 0.3 A 492 was selected to differentiate be-
tween cannulas contaminated with more or less than 2 X 10- 5
mL ofblood per l-crn-long cannula segment, which would repre-
sent maximal carryover of6 and 60 ng of plasma fibronectin and
fibrin(ogen), respectively.
Chemicals and materials. [3H]thymidine, purified human fi-
bronectin, serum albumin, and fibrinogen were obtained as pre-
viously described [8, II].
Preparation of purified fibrinogen and fibronectin fragments.
Fragment X offibrinogen was obtained by limited proteolysis of
the purified native protein with plasmin for 2 h at 37°C. Frag-
ment X was purified from the digestion mixture containing still
intact fibrinogen, fragments X and Y, and some fragment D by
gel filtration on Sephacryl S-300 (Pharmacia, Uppsala, Sweden)
until the purity was >90%, as verified by SDS-PAGE [24] and
showing a protein of 250-270 kDa.
Fibrinogen was more extensively hydrolyzed by plasmin to
the major fragments D and E in the presence of I mM Ca2+ for
16 h at 37°C. Fragment D was isolated from this lysate byaffin-
ity chromatography on Gly-Pro-Arg-Pro-Lys-Fractogel as de-
scribed previously [25]. The purity of fragment D was >95% as
verified by SDS-PAGE [24], and fragment D was identified as
fragment D) with a molecular mass of90 kDa. Fragment D3was
prepared from pure fragment D) by proteolysis with plasmin for
16 h at 37°C in the absence of'Ca"' (achieved by the addition of
EDTA, final concentration 2 mM). Digestion to fragment D3
was checked by SDS-PAGE (unreduced and reduced [24]).
Fragment D3 had a molecular mass of 75 kDa and showed a
typical pattern in the reduced gels.
A mixture of two high-molecular-mass tryptic fragments of
fibronectin, lacking the 27-kDa amino terminal end containing
as. aureus-binding domain [15, 26] and previously referred to
as the 180-kDa carboxy-terminal fragment [15], was prepared
by trypsin digestion as previously described in detail [15]. These
fragments, appearing as two closely spaced bands on SDS-
PAGE (190 and 200 kDa), have subsequently been shown to be
produced from the A and B chains, respectively [27], and to
contain the collagen, heparin, and cell-binding regions, but not
the carboxy-terminal end including the disulfide bonds connect-
ing both subunits of fibronectin [27, 28]. The mixture of 190-
and 200-kDa fragments was purified from the 27-kDa fragment
by chromatography on DEAE-Sepharose. Further purification
and characterization of the 190- and 200-kDa fragments was
done by affinity chromatography on gelatin-Sepharose and SDS-
PAGE [24], respectively.
Preparation ofanti-fibronectin antibodies. Rabbit antibodies
to human fibronectin were prepared as previously described [29,
30]. Briefly, antisera from immunized rabbits were adsorbed
onto insolubilized fibronectin-free plasma proteins, and immu-
noglobulins G were purified by affinity chromatography on pro-
tein A-Sepharose (Pharmacia). A portion of the rabbit immuno-
globulins was also selectively depleted ofantifibronectin activity
by affinity chromatography on fibronectin-Sepharose [31]. This
latter preparation was used to evaluate the nonspecific binding
of antifibronectin-unrelated IgG by the in vivo protein-coated
catheters.
Labeling of immunoglobulins, fibronectin, fibrinogen, or
fragments. Antifibronectin-containing or -depleted prepara-
tions ofIgG, native fibronectin or fibrinogen, fragments X and
D3of fibrinogen, and the mixture of 190- and 200-kDa tryptic
fragments offibronectin were radiolabeled with 3H by reductive
methylation as previously described [32]. The specific activity of
the various radiolabeled proteins ranged from 1.0 to 2.5 X 105
cpm/J.Lg protein.
Quantification of surface-bound fibronectin or fibrinogen.
Immunologic and functional assays of surface-bound fibronec-
tin were run with a single type of standard curve, which was
generated by in vitro adsorption of the purified protein on l-cm-
long segments ofuninserted cannulas. Uninserted cannulas had
to be precoated with gelatin to optimize adsorption from protein
concentrations < I mg/ml., Gelatin precoating was done by in-
cubating each cannula segment at 20°C for I h in a l-ml, puri-
fied gelatin (Difco, Detroit) solution (I mg/mL) in PBS (using
sterile polystyrene tubes).
After cannulas were rinsed in PBS, standard amounts offibro-
nectin were adsorbed by incubating at 37°C for I h duplicate
segments ofgelatin-precoated cannulas with protein concentra-
tions ranging from 4.0 to 0.125 J,Lg/mL of PBS. Similar incubat-
ing conditions were used to coat native cannulas with standard
amounts of fibrinogen, either with protein concentrations rang-
ing from 4.0 to 0.125 J,Lg/mL or at higher concentrations (8, 100,
and 1000 J,Lg/mL). The amount of surface-bound fibronectin or
fibrinogen on the cannula segments was estimated by incubat-
ing the cannula segments with the preindicated concentrations
of either radio labeled protein. At the end of the adsorption pe-
riod, each cannula segment was first rinsed twice in PBS, then
immersed in 5 mL of an emulsion system (Hionic-Fluor: Pack-
ard, Zurich) selected for scintillation counting. The standard
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amounts of either fibronectin or fibrinogen adsorbed on each
segment were estimated by multiplying counts per minute
(cpm) values of cannula-adsorbed radioactivity by the nano-
gram-to-cpm ratio of the proteins in solution. By using these
experimental conditions, the quantity ofsurface-bound fibronec-
tin and fibrinogen on each cannula segment increased linearly
in the range of protein concentration from 0.125 to 1.0 J-Lg/mL.
Under these conditions, the proportion of protein adsorbed on
the cannula segments averaged 10% and 7%for fibronectin and
fibrinogen, respectively, of the quantity initially added in solu-
tion (not shown). Identical procedures of protein adsorption
and quantification were used, when fragments ofeither fibronec-
tin or fibrinogen, prepared and radiolabeled as described above,
were adsorbed on segments of uninserted cannulas.
Adherence-promoting activity ofin vitro or in vivo cannula-ad-
sorbed proteins. One-centimeter-long segments of either unin-
serted cannulas coated in vitro with standard amounts of puri-
fied proteins or of cannulas removed from patients were
incubated at 37°C for 1 h in a previously described [II, 31, 33]
bacterial adherence assay. Briefly, cannula segments were incu-
bated with a constant inoculum of 4 X 106 cfu of a freshly
washed culture of S. aureus, metabolically radiolabeled with
[3H]thymidine in Mueller-Hinton broth [31, 33]. The isolates of
S. aureus tested for adherence were either 6 bacteremic isolates
collected from iv device infections in a previous study [8] or a
single laboratory strain (Cowan I) previously shown to have
high affinity to surface-bound fibronectin and fibrinogen [II].
Each cannula segment was incubated with the bacterial sus-
pension for 60 min in the attachment medium [31, 33] (I mL of
PBS supplemented with 5 mg/ml. purified human albumin
[PBSA]) to minimize nonspecific attachment [II] to cannula
areas that might be unexposed to plasma proteins (e.g., the lu-
men). Thereafter, cannula segments were carefully rinsed [II,
31, 33], and the number of staphylococci specifically bound
either to in vitro protein-coated or to inserted cannula segments
was estimated by counting radioactivity in a liquid scintillation
counter and by multiplying radioactive counts by the colony-
forming units-to-cpm ratio of the radiolabeled culture [II,
31,33].
Immunologic assay of cannula-adsorbed fibronectin. Seg-
ments (I em long) of cannulas, whether coated with standard
amounts of fibronectin as described above or removed from pa-
tients, were incubated at 37°C for I h with a I-mL solution
containing 10 J-Lg of a mixture of radiolabeled (l05 cpm) and
unlabeled IgG, in PBSA supplemented with 0.1% Tween 20
(PBSAT). Duplicate segments were incubated in parallel with
either antifibronectin-containing or -depleted IgG. At the end of
the binding period, cannula segments were rinsed twice in
PBSAT and counted in a liquid scintillation counter for evaluat-
ing IgG-bound radioactivity. The quantity oflgG bound to each
cannula segment was obtained by multiplying each cpm value
by the nanograms of IgG-to-cpm ratio of the incubating solu-
tion. The amount ofspecifically bound antifibronectin IgG anti-
bodies represented the quantity in excess of the background lev-
els of IgG bound by cannula segments incubated with
antifibronectin-depleted IgG. The amount of immunoreactive
fibronectin on inserted cannulas was estimated by comparing
the quantity of antifibronectin antibodies bound by these cath-
eters with antibody binding by standard amounts of surface-
bound fibronectin, adsorbed in vitro on gelatin-precoated can-
nula segments as described above.
Radioimmunoassay of cannula-adsorbed fibrin(ogen). The
procedure for estimating the total amount offibrinogen or fibrin
deposited on inserted cannulas has been previously described in
detail [II, 34]. After extensive digestion by plasmin of l-crn-
long sections of cannulas, the protein digests were assayed for
the amount of the late soluble fragment E, which remains stable
under these conditions [34]. From the amount of fragment E,
estimated by RIA using a specific antiserum [34], the quantity of
cannula-associated fibrin(ogen) was calculated on the basis ofa
molecular weight ratio of 48,500 for fragment E to 340,000 for
native fibrinogen.
Proteolytic digestion ofcannula-adsorbedfibrinogen orfibronec-
tin by plasmin. One-centimeter-long segments of native
PUR-V cannulas were coated in vitro with either fibrinogen or
fibronectin, 130 ng/cm, by a 60-min incubation at 37°C in PBS
solutions of either 2 J-Lg/mL fibrinogen or fibronectin. An addi-
tional group of uninserted but gelatin-precoated cannulas was
coated in vitro with 50 ng/cm fibronectin in a PBS solution of
0.5 J-Lg/mL. After rinsing in PBS, the protein-coated cannula
segments were exposed at 37°C to I J-Lg/mL plasminogen acti-
vated to plasmin by 800 units/ml, urokinase (Choay, Paris) in
PBS supplemented with 1 mM Ca2+ and 0.5 mM Mg2+. After
either 10 or 60 min, the digestion was terminated by adding 10
J-LL of 10-2 M o-phenyl-prolyl-arginyl-chloromethyl ketone
(PPACK; Bachem, Bubendorf, Switzerland) solution as previ-
ously described [25]. Zero time digestion controls were cannula
segments incubated for 60 min with PPACK-inactivated plas-
minogen-urokinase mixture. Control or plasmin-digested can-
nula segments were then rinsed for 5 min in PBS and tested for
residual adherence-promoting activity with S. aureus Cowan as a
test strain.
Statistical evaluation ofdata. Correlation ofbacterial adher-
ence-promoting activity with the content of immunologically
assayed fibronectin or fibrin(ogen) on inserted cannulas was ex-
pressed by Pearson's product moment coefficient as determined
by a statistical computer program (Hewlett-Packard, [model 41-
C computer] Geneva). Intergroup differences in bacterial adher-
ence-promoting activity, fibronectin, or fibrin(ogen) content of
each category of inserted cannulas were evaluated by Mann-
Whitney test for unrelated rankable scores. All statistical analy-
ses were two-tailed; a P of .05 was considered statistically signifi-
cant.
Results
Adherence of S. aureus on in vitro versus in vivo protein-
coated cannulas. Adding 25 ng/cm fibronectin to gelatin-
precoated PUR-V cannulas in vitro increased adherence of6
bacteremic isolates ofS. aureus that were previously isolated
from iv device infections [8] by a factor of4.8-fold over gela-
tin-precoated and 15.0-fold over albumin-precoated cannula
segments (figure lA). For comparison, PUR-V cannulas
coated with various amounts of purified fibrinogen (66-610
ng/cm) also promoted adherence of the 6 bacteremic isolates
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(figure 1B). S. aureus Cowan I, first described as a clinical
isolate responsible for hematogenous septic arthritis in hu-
mans [35], was promoted by the different proteins deposited
on PUR-V cannulas to the same extent as the 6 bacteremic
isolates (figure I). Of note, even dilute solutions of fibrino-
gen (e.g., 8 JIg/mL), which resulted in a deposition of 403
ng/cm (figure lB), could saturate the system for S. aureus
adherence. No further increase in S. aureus adherence was
obtained by coating the cannulas with a 125-fold higher con-
centration offibrinogen that approached its plasma level (fig-
ure 1B). Neither soluble fibronectin nor fibrinogen blocked
S. aureus Cowan I adherence to catheters coated with fibro-
nectin or fibrinogen, respectively (not shown).
Because Cowan I is a stable strain with adherence proper-
ties similar to those ofthe bacteremic isolates ofS. aureus. we
compared its adherence characteristics on in vitro protein-
coated cannulas (figure 2A) with those on ex vivo catheters
removed from patients (figure 2B). Eighty catheters were ob-
tained from 80 patients: 65 PUR or PVC cannulas and 15
Hickman catheters. Bacterial adherence studies revealed sta-
tistically significant differences between different groups of
inserted cannulas (figure 2B), suggesting different contents
or activity of adherence-promoting proteins. PUR cannulas
of each type promoted a significantly lower adherence of S.
aureus than PVC (P < .01, Mann-Whitney) or Hickman (P <
.001, Mann-Whitney) cannulas. PUR-S cannulas showed
even a smaller adherence-promoting activity (P < .002,
Mann-Whitney) than PUR-V and PUR-C cannulas that
showed equivalent results (figure 2B). PUR cannulas were
also the only material for which a nonadherence profile was
found: 40% of PUR-V, 90% of PUR-S, and 55% of PUR-C
cannulas (figure 2B) promoted S. aureus adherence less than
twofold over gelatin-coated controls and also less than can-
nulas coated in vitro with only 15 ng/cm fibrinogen (figure
2A). In contrast, all inserted PVC (n = 14) and Hickman (n
= 15) catheters significantly promoted S. aureus Cowan I
adherence (by ;;::02.0- and 5.5-fold, respectively) over gelatin
controls.
To evaluate the possible influence of plasma protein con-
tamination on these data (figure 2B), we analyzed removed
cannulas considered to be contaminated by minute amounts
of blood (see Methods) and those considered to be un-
contaminated. Separate analysis of the latter subgroup (n =
49) further confirmed that all three categories of inserted
PUR cannulas showed an overall smaller adherence-promot-
ing activity than PVC or Hickman cannulas (figure 2B).
These findings ruled out that various levels ofplasma protein
contamination were responsible for the differences in staphy-
lococcal adherence promoted by the different types of in-
serted cannulas.
Correlation analysis ofadherence-promoting activity for in-
serted catheters with their content ofimmunologically assayed
fibronectin andjibrin(ogen). Further l-cm-long segments of
inserted cannulas, adjacent to those assayed for adherence-
promoting activity, were compared for the presence offibro-
nectin or fibrin( ogen). To avoid overestimates of either pro-
tein that would result from blood contamination of
cannulas, we focused our immunologic assays on cannulas of
adequate length that were found to be uncontaminated by
peroxidase assay. These were 23 inserted cannulas: 11 PUR,
7 PVC, and 5 Hickman. Overall amounts offibronectin (fig-
ure 3A) differed from those offibrin(ogen) (figure 3B) by at
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least two orders of magnitude, ranging from 0 to 37 ng/cm
for fibronectin and from 290 ng to 5.64 J..Lg/cm for fi-
brineogen). Each category of inserted catheters yielded a sig-
nificantly different content ofimmunologically assayed fibro-
nectin (figure 3A). Median values of fibronectin were 2
ng/cm (range, 0-13) for PUR versus 8.3 ng/cm (range,
5-14; P < .05, Mann-Whitney) for PVC versus 19.5 ng/cm
(range, 11.2-37.0; P < .002, Mann-Whitney) for Hickman
cannulas. The adherence-promoting activity ofeach group of
inserted cannulas shown in figure 3A paralleled their fibro-
nectin content, each group being significantly different from
other groups (P < .002 for Hickman and PVC vs. PUR can-
nulas; P < .02 for Hickman vs. PVC cannulas; Mann-
Whitney).
No significant differences (P > .05, Mann-Whitney) were
observed in the median fibrin( ogen) content of either PUR
(0.47 J..Lg/cm), PVC (0.38 J..Lg/cm) , or Hickman cannulas
(1.02 J..Lg/cm). When all cannulas assessed for their protein
contents were pooled (n = 23), the extent ofS. aureus adher-
ence promoted by inserted cannulas was significantly corre-
lated (Pearson's r = .66, P < .002) with their content of
immunologically assayed fibronectin (figure 3A) but not (r =
.14, P> .1) fibrin(ogen) (figure 3B).
Selective inactivation ofadherence-promoting activity offi-
brin(ogen) over fibronectin adsorbed on inserted cannulas.
The apparent lack of correlation between the fibrin( ogen)
content of inserted cannulas and their adherence-promoting
activity might not be a sufficient argument to exclude the
contribution of fibrin( ogen) to S. aureus adherence. Saturat-
ing amounts of this protein may prevent observation of any
further dose-dependent promotion of bacterial adherence.
We compared S. aureus Cowan I adherence-promoting activ-
ity of each group of previously inserted catheters with that of
the same materials in vitro coated with native fibrinogen (fig-
ures 2B, 3). The residual bacterial adherence promoted by
the fibrin( ogen) layer recovered on inserted cannulas was
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indeed much lower than that promoted by equivalent
amounts of native fibrinogen in vitro coating the same mate-
rials. The extent of bacterial adherence promoted by ex vivo
fibrin( ogen) for each group of inserted cannulas (figure 3A)
represented the activity of very low amounts of in vitro-
added fibrinogen, namely 6-26 rig/em (median, 8) for PUR,
15-26 rig/em (median, 23) for PVC, and 31-70 ng/cm (me-
dian, 45) for Hickman cannulas. These median values of
functionally active adherence-promoting fibrinogen, as esti-
mated for each group of inserted cannulas, indicated an ex-
tensive loss ofactivity for ex vivo fibrin( ogen), reaching 98%,
94%, and 96%for PUR, PVC, and Hickman cannulas, respec-
tively.
In contrast to fibrin( ogen), we found no discrepancy be-
tween the quantities of immunologically assayed fibronectin
and their adherence-promoting activity on inserted cannu-
las. The quantities of fibronectin on ex vivo catheters were
adequate to promote S. aureus Cowan I adherence in the
absence of any other major attachment protein. The median
quantities of in vitro-added fibronectin (figure 2A) that pro-
moted bacterial adherence to the same extent as inserted
cannulas (figure 3A) were estimated to be 2.2 versus 2 ng/cm
for PUR, 9 versus 8.3 ng/cm for PVC, and 22.2 versus 19.5
ng/cm for Hickman cannulas. Thus, amounts of fibronectin
recovered from previously inserted PUR, PVC, or Hickman
cannulas were equivalent to those determined to signifi-
cantly promote S. aureus adherence once coated in vitro
onto each type of catheter.
To further analyze the selective inactivation of fi-
brineogen) over fibronectin on inserted catheters, we per-
formed SDS-PAGE and made immunoblots ofcannula-asso-
ciated proteins extracted in SDS-Laemmli buffer [24].
SDS-PAGE showed a very selective deposition on the cath-
eter surface of fibrinogen and fibrin, followed by smaller
amounts of plasminogen and fibronectin, respectively. Im-
munoblots of the proteins separated by SDS-PAGE (data not
shown) confirmed the identification of fibrinogen, fibrin,
plasminogen, and fibronectin as major components of can-
nula-extracted proteins. This indicated a selective protein
adsorption process from plasma to inserted cannulas, as fur-
ther supported by the absence ofalbumin or any other major
proteins in silver-stained SDS-PAGE of cannula protein ex-
tracts [36]. Immunoblots also revealed the presence of pro-
teolytic fragments of fibrinogen, fibrin, and fibronectin in
cannula-extracted proteins.
Effect ofproteolytic digestion on adherence-promoting activ-
ity 0/fibrinogen or fibronectin. Proteolytic fragments of fi-
brinogen and fibronectin were produced either by standard
techniques in the liquid phase or by in situ digestion of the
native proteins already adsorbed on cannula segments. Fig-
ure 4 shows results of studies done for convenience with a
single type of cannula (PUR-V) coated with standard frag-
ments of either fibrinogen or fibronectin that were produced
in the liquid phase and then adsorbed on cannula segments.
Comparative adherence-promoting activities of native fi-
brinogen with its plasmin fragments [19, 20, 37-40] showed
a significant loss of activity for the latter fragments (figure
4A). Whereas optimal promotion ofS. aureus Cowan I adher-
ence was achieved with 60 ng of native fibrinogen per l-cm
segment of PUR-V cannula, a fivefold greater amount of
fragment X [37-40], which is the first by-product ofplasmin-
digested fibrinogen (removing essentially the carboxy-termi-
nal part of the a chain), was required to obtain a similar
activity. More extensive cleavages at concordant locations in
the a, (3, and 'Y chains of fibrinogen, which led to separation
of their D and E domains [19, 20, 37-40], resulted in an
extensive loss of adherence-promoting activity. Whereas the
large (early) D) fragment containing a staphylococcal clump-
ing domain [19, 20] still slightly promoted S. aureus adher-
ence at 300 ng/ l-cm segment, the smaller (late) D3 fragment
devoid of staphylococcal clumping domain [19, 20] demon-
strated complete loss ofadherence-promoting activity (figure
4A). Other cannula types (PUR-S, PUR-C, PVC) coated
with high amounts of fibrinogen fragment D) or D 3 (>300
ng/ l-crn segment) also showed a greatly reduced adherence-
promoting activity for S. aureus Cowan I, when compared to
native fibrinogen (data not shown). Finally, each of the 6
bacteremic isolates of S. aureus showed an extensive loss of
adherence-promoting activity, similar to that of strain
Cowan I, when tested on PUR-V cannulas coated with frag-
ment D) versus native fibrinogen.
In contrast to fibrinogen, fragmented fibronectin could
still adequately promote S. aureus Cowan I adherence [16,
41]. Previous reports confirmed that the amino-terminal 27-
kDa tryptic fragment bound specifically to S. aureus in sus-
pension [15] or after adsorption on surfaces [16, 41]. We also
found a significant adherence-promoting activity in a mix-
ture of 190- and 200-kDa tryptic fragments lacking both the
amino- and carboxy-terminal ends of fibronectin [27, 28].
The mixture of 190- and 200-kDa fragments adsorbed on
gelatin-precoated cannula segments in parallel with intact
fibronectin promoted S. aureus Cowan I adherence at equiva-
lent amounts of adsorbed protein, although to a slightly
lower extent (figure 4B). Similar data (not shown) were ob-
tained with each of the 6 bacteremic isolates ofS. aureus; all
showed the presence of an additional S. aureus-binding do-
main outside the amino-terminal end of fibronectin.
To further confirm the higher susceptibility to proteolytic
digestion of surface-bound fibrinogen versus fibronectin, we
tested the residual adherence-promoting activity ofeach pro-
tein adsorbed in vitro on PUR-V cannula segments before
plasmin digestion. Surface-bound fibrinogen (130 rig/em)
lost its adherence-promoting activity more rapidly and more
extensively than surface-bound fibronectin exposed to plas-
min digestion (figure 5). After 10 and 60 min, plasmin-
treated cannula-bound fibrinogen still expressed only 30%
and <4% of residual adherence-promoting activity, respec-
tively. In contrast, similarly treated plasmin-treated cannula
segments, whether coated with 120 or 50 ng/cm fibronectin
on native or gelatin-precoated cannulas, respectively,
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Figure 4. Adherence-promoting
activity of selected fragments of ei-
ther fibrinogen (A) or fibronectin
(B) on S. aureus Cowan I. A, Either
native fibrinogen or a purified frag-
ment was adsorbed in vitro on un-
inserted l-cm-long segments of
polyurethane (PUR) cannulas
from concentrations ranging from
125 ng to 8 J,Lg/mL. B, Similar
amounts of native fibronectin or of
its 190- and 200-kDa tryptic frag-
ments were adsorbed in vitro on gel-
atin-coated PUR cannulas from
concentrations of 125 ng/rnl, to 2
J,Lg/mL. Results are means of 2 ex-
periments done in duplicate.
to fibrin(ogen), fibronectin, or both. The present study al-
lows definition of their respective contributions more accu-
rately. While catheters removed from patients contained
small amounts of fibronectin, this amount was sufficient to
promote a dose-dependent adherence ofall clinical strains of
S. aureus that were tested. Although immunologically reac-
tive fibrin( ogen) was found at higher amounts on cannulas
than was fibronectin, it lacked adherence-promoting activity
for S. aureus. The results clearly indicate that fibrin(ogen) is
selectively more inactivated than fibronectin on chronically
inserted cannulas. This selective inactivation process was
documented by bacterial adherence assays showing a selec-
tive loss of adherence-promoting activity for fibrin(ogen)
over fibronectin due to plasmin digestion.
S. aureus Cowan I was selected as a test organism to probe
for the presence of low levels of fibrin( ogen) and fibronectin
on the surface of inserted cannulas. This strain was shown to
have several characteristics typical of clinical isolates of for-
eign body infections, namely a high affinity to native fibrino-
gen and fibronectin and a selective. affinity for fragmented
fibronectin but not fibrinogen; Although we cannot exclude
that other plasma proteins, such as collagen [13, 17], laminin
[8, 17, 22], vitronectin [23, 42], or thrombospondin [43],
might have been present in trace amounts on cannula pro-
tein extracts analyzed by SDS-PAGE, further studies are
needed to evaluate their possible contribution to S. aureus
attachment to intravascular devices.
Several lines of evidence suggest that proteolysis of fibrin-
ogen tends to decrease S. aureus adherence. Two previous
studies [44, 45] show that fibrinogen is more susceptible to
proteolytic breakdown after adsorption on artificial surfaces
than in the liquid phase. Surface-adsorbed fibrinogen could
be degraded by activation of trace amounts of surface-ad-
sorbed plasminogen [44, 45]. Our in vitro studies with puri-
fied fibrinogen fragments showed that limited fibrinogen deg-
radation resulted in decreased S. aureus binding. In support
of our data are studies showing that a substantial proportion
ofS. aureus adherence-promoting activity is lost by a limited
plasmin digestion of fibrinogen leading to fragment X and
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Discussion
showed a significantly higher (P < .05, paired t test) residual
adherence-promoting activity, averaging 73% and 88% at 10
min and 34% and 27% at 60 min, respectively, of zero time
digestion controls (figure 5).
Previously, we demonstrated that most of the functional
adherence-promoting activity of inserted catheters was due
O+-----y---,---,.----r---,-----'ii------l
o 10 20 30 40 50 60
Time of plasmin digestion ( min)
Figure 5. Differential loss of adherence-promoting activity for
cannula-adsorbed fibrinogen or fibronectin exposed to plasmin. Re-
sidual S. aureus Cowan I adherence-promoting activity of fibrino-
gen, adsorbed at 130 ng/cm, is compared to that of fibronectin,
adsorbed at either 120 rig/em on native or 50 ng/cm on gelatin-pre-
coated polyurethane cannulas, after various times ofplasmin diges-
tion. Results are means of 3 experiments ± SE.
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thus before removal of the staphylococcal clumping domain
[19, 20]. Further plasmin degradation leads to extensive loss
of adherence-promoting activity. Our data suggest that the
previously described model for staphylococcal clumping by
fibrinogen [19, 20] does not apply to surface-bound fibrino-
gen because the clumping domain is either poorly exposed
after adsorption offibrinogen fragments on PUR cannulas or
destroyed by plasmin degradation.
While fibronectin adsorbed on inserted cannulas was pre-
sumably also sensitive to plasmin, its adherence-promoting
activity seemed to be more resistant to proteolytic degrada-
tion than surface-adsorbed fibrin( ogen). Data (shown in fig-
ure 5) demonstrated that multiple S. aureus-binding regions
were still expressed after limited proteolytic attack by differ-
ent, nonoverlapping fragments of fibronectin. These in vitro
data agree with previous observations [16, 41] showing the
presence of secondary S. aureus-binding region(s) of fibro-
nectin, contributing to bacterial adherence, in addition to
the initially described S. aureus-binding domain located in
the 27-kDa amino-terminal segment [15, 16, 18, 41).
Whereas we found this secondary binding site in a mixture of
190- and 200-kDa tryptic fragments of fibronectin, which
excluded the presence of the amino-terminal domain of the
protein, a recent report has localized this site within the hepa-
rin-binding domain of fibronectin [46].
Quantitative analysis of cannula-bound fibronectin and
fibrin( ogen) by SDS-PAGE and immunoblots was hampered
by the presence of non migrating proteins, which were pre-
sumably factor XIIIa-cross-linked oligomers known to have
molecular sizes preventing them from entering SDS-PAGE
[37-39). Despite these limitations, SDS-PAGE and immuno-
blots still convincingly showed that fibrin( ogen) was the ma-
jor component of cannula-associated proteins on most clini-
cal specimens analyzed. Fibronectin is also present on the
surface ofcatheters and appears as the predominant S. aureus
ligand on ex vivo catheters. Ofinterest, cross-linked fibronec-
tin has been shown in some studies [12, 47], but not in others
[9, 48], to enhance S. aureus adherence to thrombi.
In. summary, fibronectin has a predominant role over fi-
brin(ogen) for promotion of S. aureus adherence to inserted
iv catheters harvested from humans. The role of a selective
inactivation process ofsome cannula-adsorbed proteins, pos-
sibly contributing to the lower S. aureus adherence-promot-
ing activity of PUR versus PVC or Hickman cannulas re-
mains to be established. We hope that our experimental
approach will contribute to an improved molecular under-
standing of in vivo adherence-promoting activity ofbiomate-
rials and to the evaluation of preventive measures that make
these materials less susceptible to staphylococcal coloniza-
tion and infection.
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